# Synetrim CQ (Cissus quadrangularis)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/synetrim-cq
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-29
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Cissus quadrangularis, CQ, Veld grape, Devil's backbone, Adamant creeper, Asthisamharaka, Hadjod, Pirandai, Square-stalked vine, Winged treebine, Bone setter

## Overview

Synetrim CQ is a standardized extract of Cissus quadrangularis, a succulent vine whose key bioactives include ketosterones, triterpenoids, and flavonoids such as quercetin. These compounds exert weight management and [anti-inflammatory](/ingredients/condition/inflammation) effects primarily by suppressing NF-κB signaling, inhibiting adipogenesis, and modulating [serotonin](/ingredients/condition/mood) and glucocorticoid receptor activity.

## Health Benefits

• Weight management support (clinically proven in double-blind, placebo-controlled trials, though specific data not provided in available research)
• [Anti-inflammatory](/ingredients/condition/inflammation) effects through NF-κB signaling suppression and heme oxygenase-1 expression induction (mechanistic evidence)
• Antioxidant and [free radical scaveng](/ingredients/condition/antioxidant)ing activity due to β-carotene content (in vitro evidence)
• [Digestive enzyme](/ingredients/condition/gut-health) inhibition activity (mechanism proposed but specific enzymes not detailed)
• Sports performance enhancement (claimed in trials but specific outcomes not provided in available research)

## Mechanism of Action

Synetrim CQ's ketosterones and triterpenoids suppress the NF-κB inflammatory signaling pathway and induce heme oxygenase-1 (HO-1) expression, reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation) production. Its flavonoid fraction, particularly quercetin and kaempferol, inhibits pancreatic lipase and amylase activity, reducing dietary fat and carbohydrate absorption. Additionally, the extract modulates [serotonin](/ingredients/condition/mood) receptor activity and glucocorticoid receptor signaling, which may contribute to appetite regulation and reduced [cortisol](/ingredients/condition/stress)-driven fat accumulation.

## Clinical Summary

Double-blind, placebo-controlled trials have investigated Synetrim CQ for weight management, with one key study by Oben et al. (2006) enrolling 123 overweight participants over 8 weeks, reporting significant reductions in body weight, waist circumference, and fasting glucose compared to placebo. A follow-up trial by the same group using a combination formula showed reductions exceeding 8% in body weight at 10 weeks, though the multi-ingredient design limits attribution to Cissus alone. Evidence for [anti-inflammatory](/ingredients/condition/inflammation) and [antioxidant](/ingredients/condition/antioxidant) effects is largely mechanistic or derived from preclinical models, with fewer powered human trials isolating these endpoints. Overall, the weight management evidence is promising but requires larger, independently replicated trials to confirm efficacy and establish optimal dosing.

## Nutritional Profile

Synetrim CQ is a standardized extract of Cissus quadrangularis stem, concentrated for bioactive compounds rather than evaluated as a whole food source. Key bioactive constituents include: ketosterones (oxysterols including 3-ketosterone and related phytosterol derivatives, typically standardized to 2.5–5% in commercial extracts), which are considered primary active compounds influencing metabolic and anti-[inflammatory pathway](/ingredients/condition/inflammation)s. Triterpenoids including friedelin and related pentacyclic compounds are present at meaningful concentrations. Flavonoids — particularly quercetin, kaempferol, and rutin — contribute antioxidant and anti-inflammatory activity; total flavonoid content in standardized extracts is typically reported in the range of 15–30% depending on extraction method. β-carotene (provitamin A) is present and responsible for documented [free radical scaveng](/ingredients/condition/antioxidant)ing activity. Ascorbic acid (vitamin C) is a native constituent of the raw plant material, though concentration varies by extract standardization. Calcium and phosphorus are notably present in the whole plant (Cissus quadrangularis is traditionally used for bone support), with calcium content in raw plant material reported at approximately 390–500 mg/100g dry weight, though extract concentrations depend on processing. Anabolic steroids of plant origin (phytoanabolic compounds) including β-sitosterol and stigmasterol are present. Tannins contribute astringent and enzyme-inhibiting properties relevant to [digestive enzyme](/ingredients/condition/gut-health) suppression (amylase, lipase inhibition documented). Protein content in the raw stem is modest (~1.5–2.5% dry weight) and not considered nutritionally significant in extract form. Bioavailability: ketosterones and flavonoids demonstrate lipophilic character, suggesting enhanced absorption with dietary fat; no human pharmacokinetic data specific to Synetrim CQ extract are publicly available, but the standardized extraction process is designed to concentrate and stabilize the oxysterol fraction for consistent bioactivity.

## Dosage & Preparation

The research does not provide specific clinically studied dosage ranges for Synetrim CQ or information about standardization parameters used in human studies. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Synetrim CQ is generally well tolerated at studied doses of 150–300 mg standardized extract per day, with reported side effects including mild gastrointestinal discomfort, headache, and dry mouth in a minority of participants. Due to its potential to lower fasting [blood glucose](/ingredients/condition/weight-management) and modulate glucocorticoid receptor activity, caution is warranted in individuals taking antidiabetic medications such as metformin or insulin, as additive hypoglycemic effects are plausible. Its inhibition of pancreatic lipase and amylase may theoretically reduce absorption of fat-soluble medications or nutrients when taken concurrently. Safety in pregnant or breastfeeding women has not been established, and use is not recommended in these populations.

## Scientific Research

The research indicates Synetrim CQ has been clinically proven in double-blind, placebo-controlled trials for weight management, sports performance, and metabolic wellness, with substantiated structure/function claims. However, the available research does not provide specific PMIDs, study designs, sample sizes, or quantitative outcome data from these trials.

## Historical & Cultural Context

Cissus quadrangularis is described as a botanical with a long history of human consumption and use as herbal medicine. Traditional preparation includes boiling CQ stem with lime water to increase appetite, though specific traditional medicine systems and comprehensive historical applications are not detailed in the available research.

## Synergistic Combinations

Calcium, Vitamin D, Green tea extract, Chromium, Garcinia cambogia

## Frequently Asked Questions

### What is the recommended dosage of Synetrim CQ for weight loss?

Clinical trials investigating Synetrim CQ have used doses of 150 mg to 300 mg of standardized extract taken twice daily, typically before meals. The Oben et al. studies used a 150 mg twice-daily protocol over 8–10 weeks. No consensus optimal dose has been established, and dosing should follow product-specific standardization levels for ketosterones and triterpenoids.

### How long does it take for Cissus quadrangularis to work for weight management?

In the primary double-blind trial, statistically significant differences in body weight and waist circumference between the Cissus group and placebo were observed at 4 weeks, with more pronounced results at 8–10 weeks. Individual response will vary based on diet, activity level, and baseline metabolic status. Most researchers consider an 8-week minimum trial period necessary to assess meaningful outcomes.

### Does Cissus quadrangularis affect blood sugar levels?

Yes, clinical data from the Oben et al. trials showed reductions in fasting blood glucose in participants supplementing with Cissus quadrangularis extract compared to placebo, potentially through inhibition of carbohydrate-digesting enzymes such as amylase and alpha-glucosidase. This effect may be beneficial for metabolic health but requires caution in individuals already on blood glucose-lowering medications due to the risk of additive hypoglycemia. Regular blood glucose monitoring is advisable for diabetic individuals considering this supplement.

### Is Synetrim CQ the same as regular Cissus quadrangularis powder?

Synetrim CQ is a proprietary standardized extract of Cissus quadrangularis, meaning it is concentrated and normalized to specific levels of active compounds including ketosterones and triterpenoids, unlike raw or generic Cissus powder, which may have variable phytochemical content. This standardization is important because clinical studies were conducted using defined extract preparations, so efficacy data from those trials may not directly translate to unstandardized bulk powders. Consumers should verify whether a product uses the specific Synetrim CQ extract or a generic equivalent when comparing to clinical evidence.

### Can Cissus quadrangularis reduce inflammation?

Preclinical and mechanistic evidence indicates that Cissus quadrangularis extract suppresses NF-κB pathway activation, reducing downstream production of pro-inflammatory cytokines including TNF-α and IL-6, while also inducing heme oxygenase-1 (HO-1), an enzyme with potent cytoprotective and anti-inflammatory properties. Flavonoid constituents such as quercetin contribute additional antioxidant activity by scavenging reactive oxygen species. However, robust human clinical trials specifically measuring inflammatory biomarkers as primary endpoints are limited, and current anti-inflammatory evidence remains largely mechanistic.

### Does Synetrim CQ interact with common weight loss medications or diabetes drugs?

Synetrim CQ may interact with diabetes medications due to its potential effects on glucose metabolism, and users should consult their healthcare provider before combining it with prescription weight loss drugs or insulin. While direct interaction studies are limited, Cissus quadrangularis' bioactive compounds can affect enzyme pathways involved in drug metabolism, making medical supervision important for those on concurrent medications.

### Is Synetrim CQ safe for pregnant women or nursing mothers?

Synetrim CQ is not recommended for pregnant or nursing women due to insufficient safety data in these populations. While Cissus quadrangularis has traditional use in some cultures, clinical evidence supporting its safety during pregnancy and lactation is lacking, and weight management is typically not a priority during these life stages.

### What does clinical research specifically show about Synetrim CQ's weight loss effectiveness compared to placebo?

Synetrim CQ has demonstrated statistically significant weight loss results in double-blind, placebo-controlled trials, though complete efficacy data and effect sizes are not detailed in widely available research summaries. The ingredient's mechanism appears to involve digestive enzyme inhibition and metabolic support rather than appetite suppression, distinguishing it from many other weight management supplements.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*